NCT03216863 Home Respiratory Rehabilitation in Advanced Lung Cancer Chemotherapy Per os Status TERMINATED Phase NA
NCT03216109 Improving Supportive Care For Patients With Thoracic Malignancies Status COMPLETED Phase NA
NCT03215537 Development of Patient Tailored Guideline of Physical Activity for Lung Cancer Status UNKNOWN Phase NA
NCT03212469 A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03211078 ENB and Photodynamic Therapy in the Treatment for Early Lung Cancer Status UNKNOWN Phase NA
NCT03201146 Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC Status UNKNOWN Phase PHASE1/PHASE2
NCT03199586 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT03198468 Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) Status COMPLETED Phase NA
NCT03198052 GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers Status RECRUITING Phase PHASE1
NCT03195491 A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia Status COMPLETED Phase PHASE3
NCT03192501 iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray Status RECRUITING Phase N/A
NCT03189277 A Hospital Based Survey on Lung Cancer Related-pain in Northern China Status UNKNOWN Phase N/A
NCT03185754 Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer Status UNKNOWN Phase NA
NCT03183232 Safety and Efficiency of γδ T Cell Against Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03177291 Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC Status COMPLETED Phase PHASE1
NCT03175224 APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Status RECRUITING Phase PHASE2
NCT03170206 Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1